About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5805 record(s)
Req # A-2019-001927
Adverse Reaction Report (AER) for Cuvitru. Report number: 000732250.Organization: Health Canada
March 2020
Req # A-2019-001958
Adverse Reaction Report (AER). Report numbers: E2B_02777617, E2B_02779836.Organization: Health Canada
March 2020
Req # A-2019-001959
Adverse Reaction Report (AER). Report numbers: 000731315, E2B_02843753, E2B_02851346, E2B_02852105.Organization: Health Canada
March 2020
Req # A-2019-001971
Adverse Reaction Report (AER). Report number: 000731565.Organization: Health Canada
March 2020
Nothing to report this month
Organization: Sahtu Land and Water Board
Req # A-2013-000029
Correspondence between the sponsor and Health Canada relating to the approval of APO-MOMETASONE (AQUEOUS NASAL SPRAY).Organization: Health Canada
February 2020
Req # A-2016-000178
Reviewer’s notes for Estragyn Vaginal Cream (Estrone Vaginal Cream) marketed by Searchlight Pharma Inc.Organization: Health Canada
February 2020
Req # A-2016-000926
All records describing substantive changes to the organizational structure of the Healthy Environments and Consumer Safety Branch for the period July 27, 2016 to October 25, 2016.Organization: Health Canada
February 2020
Req # A-2016-001269
All notifiable changes relating to Mint Pharmaceutical Inc.’s Mint-Tadalafil products, Drug Identification Number (DINs) 02451662, 02451670, 02451689 and 02451697.Organization: Health Canada
February 2020
Req # A-2016-001518
Records of communications between Health Canada Tobacco Control Directorate staff and foreign governments related to tobacco warning labels during 2016.Organization: Health Canada
February 2020